Tango Therapeutics (NASDAQ:TNGX) was upgraded by analysts at Wall Street
Tango Therapeutics, Inc. (TNGX)
Company Research
Source: MarketBeat
Impact Snapshot
Event Time:
TNGX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TNGX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TNGX alerts
High impacting Tango Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
TNGX
News
- Tango Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026GlobeNewswire
- DUB Inhibitors Market to Witness Strong Expansion Across 7MM by 2040 Driven by the Launch of Novel Therapeutics | DelveInsight [Yahoo! Finance]Yahoo! Finance
- Does Tango Therapeutics' (TNGX) CEO Transition Clarify or Complicate Its Precision Oncology Roadmap? [Yahoo! Finance]Yahoo! Finance
- Tango Therapeutics Announces CEO Transition: Barbara Weber to Retire, Malte Peters Appointed Successor [Yahoo! Finance]Yahoo! Finance
- Tango Therapeutics Announces CEO Transition: Barbara Weber to Retire, Malte Peters Appointed SuccessorGlobeNewswire
TNGX
Earnings
- 11/4/25 - Beat
TNGX
Sec Filings
- 2/4/26 - Form 4
- 2/4/26 - Form 4
- 2/4/26 - Form 4
- TNGX's page on the SEC website